[go: up one dir, main page]

NO943949D0 - DNA som koder for proteinkomplekser med faktor VIII-C-aktivitet, samt fremstilling derav - Google Patents

DNA som koder for proteinkomplekser med faktor VIII-C-aktivitet, samt fremstilling derav

Info

Publication number
NO943949D0
NO943949D0 NO943949A NO943949A NO943949D0 NO 943949 D0 NO943949 D0 NO 943949D0 NO 943949 A NO943949 A NO 943949A NO 943949 A NO943949 A NO 943949A NO 943949 D0 NO943949 D0 NO 943949D0
Authority
NO
Norway
Prior art keywords
factor viii
human factor
activity
domain
protein complexes
Prior art date
Application number
NO943949A
Other languages
English (en)
Other versions
NO943949L (no
Inventor
Barbara Chapman
Rae Lyn Burke
Mirella Ezban Rasmussen
Jan Moeller Mikkelsen
Original Assignee
Novo Nordisk As
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO943949L publication Critical patent/NO943949L/no
Application filed by Novo Nordisk As, Chiron Corp filed Critical Novo Nordisk As
Priority to NO943949A priority Critical patent/NO943949D0/no
Publication of NO943949D0 publication Critical patent/NO943949D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO943949A 1989-11-17 1994-10-18 DNA som koder for proteinkomplekser med faktor VIII-C-aktivitet, samt fremstilling derav NO943949D0 (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO943949A NO943949D0 (no) 1989-11-17 1994-10-18 DNA som koder for proteinkomplekser med faktor VIII-C-aktivitet, samt fremstilling derav

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US43863989A 1989-11-17 1989-11-17
PCT/DK1990/000291 WO1991007490A1 (en) 1989-11-17 1990-11-15 Protein complexes having factor viii:c activity and production thereof
NO92921946A NO921946L (no) 1989-11-17 1992-05-15 Proteinkomplekser med faktor viii:c-aktivitet, samt fremstilling derav
NO943949A NO943949D0 (no) 1989-11-17 1994-10-18 DNA som koder for proteinkomplekser med faktor VIII-C-aktivitet, samt fremstilling derav

Publications (2)

Publication Number Publication Date
NO943949L NO943949L (no) 1992-07-13
NO943949D0 true NO943949D0 (no) 1994-10-18

Family

ID=23741420

Family Applications (2)

Application Number Title Priority Date Filing Date
NO92921946A NO921946L (no) 1989-11-17 1992-05-15 Proteinkomplekser med faktor viii:c-aktivitet, samt fremstilling derav
NO943949A NO943949D0 (no) 1989-11-17 1994-10-18 DNA som koder for proteinkomplekser med faktor VIII-C-aktivitet, samt fremstilling derav

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO92921946A NO921946L (no) 1989-11-17 1992-05-15 Proteinkomplekser med faktor viii:c-aktivitet, samt fremstilling derav

Country Status (22)

Country Link
EP (2) EP0670332A3 (no)
JP (3) JP2865861B2 (no)
KR (2) KR927003812A (no)
AT (1) ATE163194T1 (no)
AU (1) AU656311B2 (no)
CA (2) CA2135744A1 (no)
DE (1) DE69032043T2 (no)
DK (1) DK0500734T3 (no)
ES (1) ES2112255T3 (no)
FI (2) FI944903A7 (no)
GR (1) GR3026176T3 (no)
HU (2) HUT70457A (no)
IE (1) IE904140A1 (no)
IL (2) IL96368A0 (no)
NO (2) NO921946L (no)
NZ (1) NZ236094A (no)
PL (1) PL167083B1 (no)
PT (1) PT95923B (no)
SK (1) SK130194A3 (no)
WO (1) WO1991007490A1 (no)
YU (2) YU218690A (no)
ZA (1) ZA909167B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE465222C5 (sv) * 1989-12-15 1998-02-10 Pharmacia & Upjohn Ab Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
US5326700A (en) * 1990-11-06 1994-07-05 Eli Lilly And Company DNA sequences encoding t-PA derivatives with cleavable sites
SE468050C (sv) * 1991-03-15 1998-04-27 Pharmacia & Upjohn Ab Rekombinant derivat av human faktor VIII
CA2078721A1 (en) * 1991-09-24 1993-03-25 Hiroshi Yonemura Process for preparing human coagulation factor viii protein complex
DK53792D0 (da) * 1992-04-24 1992-04-24 Novo Nordisk As Fremgangsmaade til fremstilling af proteiner
EP0768361A1 (en) * 1995-10-16 1997-04-16 Shin-Etsu Chemical Co., Ltd. Liquid crystal composition and liquid crystal display element comprising the same
ATE319817T1 (de) 1996-04-24 2006-03-15 Univ Michigan Gegen inaktivierung resistenter faktor viii
US8183344B2 (en) 1996-04-24 2012-05-22 University Of Michigan Inactivation resistant factor VIII
GB2318732A (en) 1996-11-01 1998-05-06 Johnson & Johnson Medical Wound healing compositions containing alpha-1-antitrypsin
US6221349B1 (en) 1998-10-20 2001-04-24 Avigen, Inc. Adeno-associated vectors for expression of factor VIII by target cells
US6200560B1 (en) 1998-10-20 2001-03-13 Avigen, Inc. Adeno-associated virus vectors for expression of factor VIII by target cells
DE60115613T2 (de) * 2000-03-22 2006-08-24 Octagene Gmbh Herstellung von rekombinanten muteine des blutgerinnungsfaktors viii in humanen zellinien
EP2292780B1 (en) 2003-09-30 2017-08-23 The Trustees Of The University Of Pennsylvania Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof
EP1707634A1 (en) 2005-03-29 2006-10-04 Octapharma AG Method for isolation of recombinantly produced proteins
EP2359865B1 (en) 2005-04-07 2013-10-02 The Trustees of The University of Pennsylvania Method of increasing the function of an AAV vector
EP1739179A1 (en) 2005-06-30 2007-01-03 Octapharma AG Serum-free stable transfection and production of recombinant human proteins in human cell lines
WO2011095604A1 (en) 2010-02-04 2011-08-11 Octapharma Biopharmaceuticals Gmbh Half-life prolongation of proteins
SG183929A1 (en) 2010-03-29 2012-10-30 Univ Pennsylvania Pharmacologically induced transgene ablation system
US9315825B2 (en) 2010-03-29 2016-04-19 The Trustees Of The University Of Pennsylvania Pharmacologically induced transgene ablation system
AU2012219380B2 (en) 2011-02-17 2017-04-13 The Trustees Of The University Of Pennsylvania Compositions and methods for altering tissue specificity and improving AAV9-mediated gene transfer
US9719106B2 (en) 2013-04-29 2017-08-01 The Trustees Of The University Of Pennsylvania Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereof
CN108093639B (zh) 2015-04-16 2022-07-19 埃默里大学 用于肝脏中蛋白质表达的重组启动子和载体及其用途
KR20230042754A (ko) 2020-08-07 2023-03-29 아미쿠스 세라퓨틱스, 인코포레이티드 소포 표적화 단백질 및 이의 용도

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652530A (en) 1967-08-28 1972-03-28 American Nat Red Cross Antihemophilic factor prepared from blood plasma using polyethylene glycol
US3631018A (en) 1970-05-01 1971-12-28 Baxter Laboratories Inc Production of stable high-potency human ahf using polyethylene glycol and glycine to fractionate a cryoprecipitate of ahf concentrate
US4069216A (en) 1975-06-16 1978-01-17 Edward Shanbrom, Inc. Simplified methods for preparation of very high purity Factor VIII concentrate
AU577259B2 (en) * 1982-08-13 1988-09-22 Zymogenetics Inc. Glycolytic promters for regulated protein expression protease inhibitor
EP0162067B1 (en) * 1983-10-28 1992-07-15 Genetics Institute, Inc. Production of factor viii and related products
DE3683980D1 (de) * 1985-04-12 1992-04-02 Genetics Inst Neue prokoagulierungsproteine.
FI98829C (fi) 1986-01-27 1997-08-25 Chiron Corp Menetelmä rekombinoidun proteiinikompleksin valmistamiseksi, jolla on humaanitekijä VIII:C-aktiivisuutta
AU588965B2 (en) * 1986-02-06 1989-09-28 Alcatel Australia Limited Telephone hook-switch

Also Published As

Publication number Publication date
GR3026176T3 (en) 1998-05-29
CA2068728A1 (en) 1991-05-18
WO1991007490A1 (en) 1991-05-30
DE69032043T2 (de) 1998-06-04
HUT64591A (en) 1994-01-28
CA2135744A1 (en) 1991-05-18
YU78194A (sh) 1997-05-28
FI922204A0 (fi) 1992-05-14
FI922204L (fi) 1992-05-14
PT95923B (pt) 1998-04-30
PL287807A1 (en) 1991-09-23
YU218690A (sh) 1993-05-28
ATE163194T1 (de) 1998-02-15
JPH11130800A (ja) 1999-05-18
EP0670332A2 (en) 1995-09-06
FI922204A7 (fi) 1992-05-14
NZ236094A (en) 1993-04-28
EP0500734B1 (en) 1998-02-11
AU6752590A (en) 1991-06-13
JPH05502025A (ja) 1993-04-15
EP0670332A3 (en) 1995-10-25
JP2865861B2 (ja) 1999-03-08
PT95923A (pt) 1991-09-13
KR960701899A (ko) 1996-03-28
PL167083B1 (pl) 1995-07-31
JPH0856656A (ja) 1996-03-05
ES2112255T3 (es) 1998-04-01
IL111304A0 (en) 1994-12-29
HUT70457A (en) 1995-10-30
HU9500546D0 (en) 1995-04-28
ZA909167B (en) 1993-10-15
NO943949L (no) 1992-07-13
FI944903A0 (fi) 1994-10-19
KR927003812A (ko) 1992-12-18
NO921946D0 (no) 1992-05-15
HU9201629D0 (en) 1992-08-28
FI944903L (fi) 1994-10-19
SK130194A3 (en) 1997-06-04
IE904140A1 (en) 1991-05-22
JP2771129B2 (ja) 1998-07-02
AU656311B2 (en) 1995-02-02
DK0500734T3 (da) 1998-03-30
DE69032043D1 (de) 1998-03-19
FI944903A7 (fi) 1994-10-19
IL96368A0 (en) 1991-08-16
NO921946L (no) 1992-07-13
EP0500734A1 (en) 1992-09-02

Similar Documents

Publication Publication Date Title
NO943949D0 (no) DNA som koder for proteinkomplekser med faktor VIII-C-aktivitet, samt fremstilling derav
ES2137931T3 (es) Proteinas gdf-1 y uog-1.
DE3650538D1 (de) Interleukin-4 protein mit bcgf- und tcgf-aktivität gegenüber menschlichen zellen (menschliches interleukin-4)
DE60033138D1 (de) Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren
ATE414775T1 (de) Polypeptide mit prolyldipeptidylaminopeptidase- aktivität und dafür kodierende nukleinsäuren
DE3587840D1 (de) Für das Polypeptid des T-Zellantigenreceptors kodierende Nukleinsäure.
NO892033D0 (no) Fibronectinbindende protein.
DE69333346D1 (de) Neuartiges p- selectin ligandenprotein
DE69837475D1 (de) Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren
DK120290A (da) Nye derivater af human/bovin basal fibroblastvaekstfaktor
EP0276778A3 (en) High level expression in e. coli of soluble mature hil-1beta and derivatives with altered biological activity
DK0805204T3 (da) Bitestikel - specifikt receptorprotein og anvendelse heraf
DK0414151T3 (da) Humane nervevæskstfaktorproteiner og fremstilling deraf
FI882238A0 (fi) Foerbaettringar i samband med organiska foereningar
ATE317896T1 (de) Polypeptide mit glucanotransferase aktivität und dafür kodierende nukleinsäuren
ATE154392T1 (de) Kalzium-geregelter promotor